首页> 外国专利> TREATING AGENT FOR HYPERLIPEMIA AND REDUCING AGENT FOR LIPID INGREDIENT IN BLOOD

TREATING AGENT FOR HYPERLIPEMIA AND REDUCING AGENT FOR LIPID INGREDIENT IN BLOOD

机译:血脂过高的治疗剂和血脂含量降低的剂

摘要

PURPOSE:To obtain a treating agent for hyperlipemia and reducing agent for lipid ingredient in blood, containing a 15-keto-prostaglandin(PG) compound as an active ingredient and capable or reducing concentrations of triglycerides, cholesterol and phospholipids. CONSTITUTION:A treating agent for hyperlipemia and reducing agent for lipid ingredient in blood containing a 15-keto-PG compound, e.g. 16-mono- or dihalo-15-keto-PG, 13,14-dihydro-16-mono- or difluoro-15-keto-PG, 6,15-diketo-PG or 15-keto-16-desbutyl-16-phenoxy-PG as an active ingredient. The aforementioned drug is used by a method for systemic or local oral administration, intravenous injection (including intravenous drip), subcutaneous injection, intrarectal administration, etc., and sufficient effects are obtained by administering the agent in a dose of normally 0.001-500mg/kg in 2-4 divided portions a day or in a sustained form.
机译:目的:获得一种高脂血症治疗剂和血液中脂质成分的还原剂,其包含15-酮-前列腺素(PG)化合物作为有效成分,并能够或降低甘油三酸酯,胆固醇和磷脂的浓度。组成:高脂血症治疗剂和血液中脂质成分的还原剂,其中含有15-酮-PG化合物,例如16-单或二卤代15-酮基PG,13,14-二氢-16-单或二氟15-酮基PG,6,15-二酮基PG或15-酮基16-去丁基16-苯氧基-PG作为有效成分。上述药物通过全身或局部口服,静脉内注射(包括静脉滴注),皮下注射,直肠内给药等方法使用,通常以0.001-500mg / mg的剂量给药可获得充分的效果。每天2-4公斤或以持续形式服用。

著录项

  • 公开/公告号JPH03163024A

    专利类型

  • 公开/公告日1991-07-15

    原文格式PDF

  • 申请/专利权人 UENO SEIYAKU OYO KENKYUSHO:KK;

    申请/专利号JP19900196742

  • 发明设计人 UENO TAKASHI;NAGAMA HIROYOSHI;

    申请日1990-07-24

  • 分类号A61K31/557;A61P3/06;

  • 国家 JP

  • 入库时间 2022-08-22 06:06:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号